Corrigendum to Annual Report for FY 2024-25 We wish to clarify that there has been no alteration to the audited financials. This corrigendum should be read in conjunction with the original ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
B2B Software Technologies has filed a corrigendum to its FY 2024-25 Annual Report, which was originally submitted on 7 September 2025 ahead of the 31st AGM scheduled for 29 September 2025 via video conferencing. The company clarified that the corrigendum only fixes factual errors and omissions spotted during internal review, and there is no alteration to the audited financial statements, AGM date/time/mode, or agenda. All other information in the original annual report remains unchanged. The full corrigendum is also available on the company's website.
A corrigendum itself is administrative and the company clarifies no change to audited numbers, so material financial impact is neutral. However, the underlying Annual Report includes some notable items for shareholders: appointment of new statutory auditors M/s M V Vijaya Kumar & Co. replacing the resigned M/s Jawahar & Associates, and approval of material related party transactions with Antelope Valley Cancer Center (owned by Promoter/CEO Dr. Ram Chandra Rao Nemani) and GeniusDocs, which warrant investor attention at the AGM.